Vaccine Breakthrough Severe COVID-19 in a Lung Recipient.

Autor: Beyoglu MA; Department of General Thoracic Surgery and Lung Transplantation, Ankara City Hospital, University of Health Sciences, Ankara, Turkey. Electronic address: muhammetalibeyoglu@gmail.com., Sahin MF; Department of General Thoracic Surgery and Lung Transplantation, Ankara City Hospital, University of Health Sciences, Ankara, Turkey., Turkkan S; Department of General Thoracic Surgery and Lung Transplantation, Ankara City Hospital, University of Health Sciences, Ankara, Turkey., Basaran FC; Department of General Thoracic Surgery and Lung Transplantation, Ankara City Hospital, University of Health Sciences, Ankara, Turkey., Yazicioglu A; Department of General Thoracic Surgery and Lung Transplantation, Ankara City Hospital, University of Health Sciences, Ankara, Turkey., Bektas SG; Department of Intensive Care Unit, Ankara City Hospital, University of Health Sciences, Ankara, Turkey., Tekce YT; Clinic of Infectious Disease, Ankara City Hospital, University of Health Sciences, Ankara, Turkey., Yekeler E; Department of General Thoracic Surgery and Lung Transplantation, Ankara City Hospital, University of Health Sciences, Ankara, Turkey.
Jazyk: angličtina
Zdroj: Transplantation proceedings [Transplant Proc] 2022 Jul-Aug; Vol. 54 (6), pp. 1569-1571. Date of Electronic Publication: 2021 Nov 12.
DOI: 10.1016/j.transproceed.2021.11.003
Abstrakt: The vaccines developed against severe acute respiratory syndrome coronavirus 2 are seen as the most crucial weapon in controlling the epidemic. It has been reported in early-stage vaccine studies that vaccines provide up to 95% protection against severe disease and mortality, even in the absence of symptomatic infection. Reports on vaccine breakthrough infections that developed after widespread vaccination are available in the literature. In addition to the general population, the course of vaccine breakthrough infections in immunocompromised patients is a matter of concern. This case report aimed to define severe coronavirus disease 2019 developing in a lung recipient who received 3 doses of inactivated virus vaccine.
(Copyright © 2021 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: